Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVSI-06-09 Sequential Booster Trial
NCT05293548Phase 2Unknown
- Sponsor
- Serum Institute of India
- Start
- May 2022
- Primary completion
- May 2023
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of BIBP-Rec-Vaccine in coronavirus disease 2019 (COVID-19), sponsored by Serum Institute of India. Status: unknown.
02
Drugs
BIBP-Rec-Vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05293548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05293548.